Ron Squarer

Director at Nuvalent · 6 reported transactions in 3 companies · latest report Jul 15, 2026

Their trades


NuvalentNUVL	Returned to company — · 6,281 shares	Jul 15, 2026
NuvalentNUVL	Share award — · 3,444 shares	Jun 16, 2026
Travere TherapeuticsTVTX	Share award — · 4,000 shares	May 19, 2026
NuvalentNUVL	Share award — · 2,837 shares	Dec 10, 2025
ADC TherapeuticsADCT	Shares withheld for tax $54.4K · 15,184 shares	Jun 13, 2025
ADC TherapeuticsADCT	Share award — · 40,000 shares	Jun 3, 2025

Returned to companyNuvalent

Jul 15, 2026 · NUVL

6,281

Share awardNuvalent

Jun 16, 2026 · NUVL

3,444

Share awardTravere Therapeutics

May 19, 2026 · TVTX

4,000

Share awardNuvalent

Dec 10, 2025 · NUVL

2,837

Shares withheld for taxADC Therapeutics

Jun 13, 2025 · ADCT

$54.4K

Share awardADC Therapeutics

Jun 3, 2025 · ADCT

40,000

6 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

← Back

Ron Squarer

Director at Nuvalent · 6 reported transactions in 3 companies · latest report Jul 15, 2026

Their trades


NuvalentNUVL	Returned to company — · 6,281 shares	Jul 15, 2026
NuvalentNUVL	Share award — · 3,444 shares	Jun 16, 2026
Travere TherapeuticsTVTX	Share award — · 4,000 shares	May 19, 2026
NuvalentNUVL	Share award — · 2,837 shares	Dec 10, 2025
ADC TherapeuticsADCT	Shares withheld for tax $54.4K · 15,184 shares	Jun 13, 2025
ADC TherapeuticsADCT	Share award — · 40,000 shares	Jun 3, 2025

Returned to companyNuvalent

Jul 15, 2026 · NUVL

6,281

Share awardNuvalent

Jun 16, 2026 · NUVL

3,444

Share awardTravere Therapeutics

May 19, 2026 · TVTX

4,000

Share awardNuvalent

Dec 10, 2025 · NUVL

2,837

Shares withheld for taxADC Therapeutics

Jun 13, 2025 · ADCT

$54.4K

Share awardADC Therapeutics

Jun 3, 2025 · ADCT

40,000

6 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Their trades

Others trading the same companies

Their trades

Others trading the same companies